Tuesday, June 18, 2024 9:14:24 AM
He has now moved on to QuidelOrtho. He apparently fulfilled his tasks for Sohm, but according to his LinkedIn, he has been doing double duty for them since March 2023, and he left Sohm as of this month. He's always been an Independent guy, probably makes good money as a contractor/consultant.
Sad to see him go, but I appreciate your balanced comments. Hoping everyone still involved has learned a thing or two from him that can be continued, and if he needs replaced, they do it soon. According to their Tweet, they are still building their team, so maybe Aguilar already is in the middle of that process. Maybe we'll see an announcement at some point.
https://www.linkedin.com/in/wm-dewey-rushing-7505a95/
https://www.linkedin.com/company/quidelortho/
HL. Upsart Biotech at .0011.
Sad to see him go, but I appreciate your balanced comments. Hoping everyone still involved has learned a thing or two from him that can be continued, and if he needs replaced, they do it soon. According to their Tweet, they are still building their team, so maybe Aguilar already is in the middle of that process. Maybe we'll see an announcement at some point.
https://www.linkedin.com/in/wm-dewey-rushing-7505a95/
https://www.linkedin.com/company/quidelortho/
HL. Upsart Biotech at .0011.
Recent SHMN News
- SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery • ACCESS Newswire • 11/06/2025 02:30:00 PM
- SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development • ACCESS Newswire • 11/04/2025 02:30:00 PM
